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Serratia marcescens cytotoxin was purified to homogeneity by ion-
exchange chromatography on a DEAE Sepharose Fast Flow column,
followed by gel filtration chromatography on a Sephadex G100 col-
umn. The molecular mass of the cytotoxin was estimated to be about
50 kDa. Some biological properties of the cytotoxin were analyzed
and compared with well-characterized toxins, such as VT1, VT2 and
CNF from Escherichia coli and hemolysin produced by S. marces-
cens. The sensitivity of the cell lines CHO, HeLa, HEp-2, Vero, BHK-
21, MA 104 and J774 to the cytotoxin was determined by the cell
viability assay using neutral red. CHO and HEp-2 were highly sensi-
tive, with massive cellular death after 1 h of treatment, followed by
BHK-21, HeLa, Vero and J774 cells, while MA 104 was insensitive to
the toxin. Cytotoxin induced morphological changes such as cell
rounding with cytoplasmic retraction and nuclear compactation which
were evident 15 min after the addition of cytotoxin. The cytotoxic
assays show that 15 min of treatment with the cytotoxin induced
irreversible intoxication of the cells, determined by loss of cell viabil-
ity. Concentrations of 2 CD50 (0.56 µg/ml) of purified cytotoxin did
not present any hemolytic activity, showing that the cytotoxin is
distinct from S. marcescens hemolysin. Antisera prepared against S.
marcescens cytotoxin did not neutralize the cytotoxic activity of VT1,
VT2 or CNF toxin, indicating that these toxins do not share antigenic
determinants with cytotoxin. Moreover, we did not detect gene se-
quences for any of these toxins in S. marcescens by PCR assay. These
results suggest that S. marcescens cytotoxin is not related to any of
these toxins from E. coli.
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Serratia marcescens has been considered
to be an important nosocomial pathogen, re-
sponsible for endemic and epidemic infec-
tions, especially in newborns and patients
submitted to invasive procedures (1-4).
Studies of the virulence factors of S. mar-
cescens demonstrated that clinical isolates
produce a toxin with activity on Vero (Afri-
can Green monkey kidney) cells in culture
(5). These strains were isolated from distinct
clinical sources and no relationship was ob-
served between cytotoxic activity and strain
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serotype. Moreover, this cytotoxic activity is
not mediated by plasmids. The S. marces-
cens toxin is extracellular and heat labile,
and optimal culture conditions were incuba-
tion at temperatures ranging from 30 to 37ºC
for 24 h under shaking in medium adjusted
to pH 8.5 (6).
Recently, it was shown that the hemol-
ysin of S. marcescens induces cytotoxic ef-
fects on human epithelial cells, character-
ized by vacuolization with subsequent cell
lysis (7). The cytopathic effects of the S.
marcescens cytotoxin correspond to cell
rounding followed by gradual destruction of
the monolayer, as observed by inverted mi-
croscopy (5). This technique is routinely
used to assess cytotoxicity in cell culture;
however, it lacks sensitivity for detecting more
details about early events of the cell injury
process. Thus, it is still unclear whether the
cytotoxin causes vacuolization and cell lysis.
We report here the purification of the S.
marcescens cytotoxin and compare its bio-




A 0.5-ml pre-culture of S. marcescens
(6) was inoculated into 500 ml Davis mini-
mal medium (8) in a 1-liter Erlenmeyer flask
with shaking at 150 rpm and incubated at
37ºC for 18-24 h. Six liters of culture from
12 such flasks was centrifuged at 10,000 g
for 15 min at 4ºC and ammonium sulfate was
added slowly to the culture supernatant to
80% saturation. After centrifugation at 10,000
g for 15 min at 4ºC, the pellet collected was
dissolved in 25 mM Tris-HCl, pH 7.0, fol-
lowed by exhaustive dialysis against the same
buffer. The preparation was applied to a
DEAE Sepharose Fast Flow column (3.0 x
9.0 cm; Pharmacia LKB Biotechnology,
Uppsala, Sweden) equilibrated with 25 mM
Tris-HCl buffer, pH 7.0, and the cytotoxin
was eluted (5-ml fractions) with the same
buffer containing 0.1 M NaCl. Fractions with
toxicity were pooled, concentrated to 5 ml
by ultrafiltration through a PM 10 membrane
(Amicon Corp., Lexington, MA, USA) and
applied to a Sephadex G100 column (2.5 x
68 cm; Pharmacia) equilibrated and eluted
(2.5-ml fractions) with 25 mM Tris-HCl buf-
fer containing 0.15 M NaCl, pH 7.0. Frac-
tions with the highest cytotoxic activity were
pooled and stored at -70ºC until use. The
total protein concentration was determined
by the method of Bradford using reagents
from BioRad (Hercules, CA, USA) and se-
rum albumin as standard (9).
Molecular mass estimation by gel filtration
chromatography
The molecular mass of the cytotoxin was
estimated by gel filtration on a Superdex 200
HR column (Pharmacia). A 0.1-ml portion
of purified cytotoxin was applied to the col-
umn equilibrated with 25 mM Tris-HCl buf-
fer, pH 7.0, and eluted at 0.25 ml/min in an
HPLC system (Shimadzu, Kyoto, Japan).
Absorbance of the cytotoxin was measured
at 280 nm and the material was collected and
assayed for cytotoxicity on Chinese hamster
ovary (CHO) cells. The molecular mass of
the cytotoxin was estimated by comparing
its elution volume with those of calibration
standards such as ribonuclease A (13.7 kDa),
chymotrypsinogen A (25 kDa), ovalbumin
(43 kDa), albumin (67 kDa) and blue dex-
tran 2000 (>100 kDa) (10).
Gel electrophoresis
The purified cytotoxin (30 µg/ml) was
assessed for purity on 8% silver-stained so-
dium dodecyl sulfate (SDS)-polyacrylamide
gel (11).
Cell lines and cytotoxic assays
Human cervical carcinoma (HeLa), Vero,
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human epidermoid carcinoma (HEp-2), baby
hamster kidney (BHK-21), CHO, mouse tu-
mor macrophage (J774) and monkey kidney
(MA 104) cells, all obtained from the Ameri-
can Type Culture Collection (Rockville, MD,
USA), were maintained in tissue culture
flasks with Eagle’s modified essential medi-
um (Gibco, BRL, São Paulo, SP, Brazil)
supplemented with 10% fetal calf serum,
and 0.75 mM L-glutamine. The J774 cells
were cultivated in RPMI medium (Gibco)
under the same conditions as described
above. The cytotoxicity assays were per-
formed as described in Ref. 6. Briefly, after
formation of a cell monolayer, the medium
was removed from each well and replaced
with fresh medium without serum and con-
taining the cytotoxin. The plates were incu-
bated in the presence of 5% CO2 at 37ºC. The
cell monolayer morphology was observed
daily under an inverted microscope in order
to detect the presence of any cytopathic ef-
fect.
Determination of cell viability and CD50
In order to compare the sensitivities of
the cell lines to S. marcescens cytotoxin, cell
viability after the cytotoxic assay was quan-
tified by the neutral red cytotoxicity assay
(6). The concentration of toxin that killed
50% of CHO cells (CD50) was calculated as
described in Ref. 12.
Morphological changes
The CHO cells were grown on coverslips
placed inside 24-well plates using 1 ml of
cell suspension (1 x 104 cells/ml) per well
and the plates were incubated at 37ºC in the
presence of 5% CO2. After 24 h, the culture
medium was aspirated and replaced with 1
ml of fresh medium and a 2 CD50 dose of
cytotoxin was added to each well. At time-
defined intervals, the coverslips were washed
with phosphate-buffered saline (PBS) and
fixed in 10% formaldehyde solution in PBS
for 1 h. The coverslips were then washed
with distilled water and stained with 0.025%
toluidine blue, pH 4.0, as described by Mello
and Vidal (13). The coverslips were washed
with distilled water, air dried, cleared in
xylene and mounted on slides using Entellan
(Merck, Darmstadt, Germany). The cellular
alterations were observed with an Axioskop
microscope (Nikon, Tokyo, Japan).
Antiserum production
Aliquots of 50 µl of a purified cytotoxin
preparation (75 µg of protein per ml) were
emulsified in an equal volume of Freund’s
complete adjuvant and injected via the in-
guinal node, with subsequent injections in
incomplete adjuvant after 2 weeks. Animals
were bled and the cytotoxicity-neutralizing
capacity of the sera was tested.
Seroneutralization assays
In order to determine whether S. marces-
cens cytotoxin antiserum could neutralize
the cytotoxicity of VT1, VT2 or cytotoxic
necrotizing factor (CNF) produced by E.
coli, seroneutralization assays were carried
out (14). Antisera produced in rabbits against
purified cytotoxin of S. marcescens were
serially diluted in Eagle’s medium and mixed
with 1/40 dilution of the test toxins. The
mixtures were incubated for 1 h at 37ºC,
applied to Vero cells and incubated for 72 h
at 37ºC. The plates were examined micro-
scopically on a daily basis for the appear-
ance of cytopathogenicity. Negative con-
trols with preimmune serum were also in-
cluded.
Hemolysis assays
The hemolytic activity of the purified
cytotoxin was assayed as previously de-
scribed (7). A 2 CD50 dose (0.56 µg/ml) of
cytotoxin was serially diluted (base 2) in
0.9% NaCl and 100-µl aliquots of each dilu-
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tion were mixed with 1 ml of erythrocyte
suspension and incubated for 30 min at 30ºC.
The mixture was then centrifuged for 3 min
at 2,500 rpm to remove unlysed erythrocytes
and cell debris. The absorbance of the super-
natants containing released hemoglobin was
measured at 405 nm. Results were compared
with total lysis (100%) caused by SDS used
as control.
Toxin gene sequence determination by
genotypic analysis (PCR)
The S. marcescens strain was screened
for the presence of gene sequences of toxins
from E. coli using primers for VT1 (ST-I),
VT2 (ST-II) (15) and CNF (16). Bacterial
DNA to be amplified was released from the
organism by boiling. The reactions were per-
formed as previously described (17) using 2
µl dNTP solution containing 20 mM of each
nucleotide, 1 µl Taq DNA polymerase (1 U/
µl), 3 µl 5 µM MgCl2, 5 µl PCR buffer, 5 µl
DNA, 1 µl of each primer (50 pmol), and 35
µl sterile Milli-Q water. The solutions were
pre-heated without the enzyme at 94ºC/10
min and submitted to 30 cycles (GeneAmp
PCR System 9700, Perkin Elmer, Foster City,
CA, USA) of 94ºC/2 min, 50ºC/2 min and
72ºC/1 min (VT2), 94ºC/2 min, 57ºC/2 min
and 72ºC/1 min (ST-I and CNF); after these
cycles they were submitted to 72ºC/7 min.
PCR products were analyzed by 2% horizon-
tal agarose gel electrophoresis with ethidium
bromide staining under UV light.
Results
Cytotoxin purification
The crude cytotoxin preparations were
initially subjected to ion-exchange chroma-
tography on a DEAE Sepharose Fast Flow
column. The column was eluted with 500 ml
of 25 mM Tris-HCl buffer at a flow rate of 1
ml/min, and the fractions containing cyto-
toxic activity were eluted with the same
buffer containing 0.1 M NaCl (Figure 1A,
horizontal bar). The cytotoxin was subse-
quently chromatographed on a Sephadex
G100 gel filtration column equilibrated with
25 mM Tris-HCl buffer containing 0.15 M
NaCl. Cytotoxic activity was eluted in the
third peak (Figure 1B, horizontal bar). Cyto-
toxin obtained at this stage presented a single
Figure 1. A, DEAE Sepharose Fast Flow column chromatography. A crude sample was
applied to a DEAE Sepharose Fast Flow column equilibrated with 25 mM Tris-HCl buffer, pH
7.0. Fractions with cytotoxic activity (5 ml) were eluted with a nonlinear gradient of 0.1 M
NaCl in the same buffer. The horizontal bar indicates the fractions pooled for subsequent
purification. B, Sephadex G100 column chromatography. The cytotoxic fractions (5 ml)
obtained from the DEAE Sepharose column were applied to a Sephadex G100 column
equilibrated with 25 mM Tris-HCl buffer, pH 7.0, containing 0.15 M NaCl. The horizontal bar
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protein band by SDS electrophoresis (Fig-
ure 2). The cytotoxin peak was eluted be-
tween the positions for bovine serum albu-
min and ovalbumin, corresponding to an
apparent molecular mass of 47 to 50 kDa on
the calibration curve.
Cytotoxicity and cell viability assays
Among the cell lines tested, CHO, HeLa,
HEp-2, Vero, BHK-21 and J774 were sus-
ceptible to S. marcescens cytotoxin and only
MA 104 cells were resistant. Although the
susceptible cell lines showed similar mor-
phological changes when exposed to cyto-
toxin, the cells were not affected to the same
extent after exposure for a specific time. The
highest sensitivity was observed with CHO
and HEp-2 cells, with the cytopathic effect
starting as early as 15 min after incubation
with toxin and resulting in the destruction of
the monolayer within 1-2 h (Figure 3). The
BHK-21, HeLa, J774 and Vero cells showed
monolayer destruction after 24 h, as deter-
mined by the viability assays. Thus, the CHO
cells were used in all experiments for the
characterization of the cytotoxin. The CD50
of the cytotoxin is defined as the highest
concentration of the sample that killed 50%
of the CHO cells after 24 h. The purified
cytotoxin had a CD50 of 0.28 µg/ml.
Morphological changes
Morphological changes induced by the
cytotoxin were studied in CHO cells stained
with toluidine blue after different incubation
periods. The first observable changes were
evident about 15 min after the addition of the
cytotoxin. The cytoplasm started to retract
and the cells became rounded, with progres-
sive nuclear compactation and extensive sur-
face blebbing being observed after 1 h (Fig-
ure 4B). The morphological changes induced
by the cytotoxin were then compared with S.
marcescens hemolysin and VT1, VT2 and
CNF from E. coli (Table 1).
Figure 2. Analysis of Serratia
marcescens cytotoxin by SDS-
PAGE using silver staining. Lane
A, Cytotoxic fraction obtained
from a Sephadex G100 column












Figure 3. Response of the CHO, HEp-2, HeLa, BHK-21, Vero, MA 104 and J774 cell lines
after different incubation periods with a 2 CD50 dose (0.56 µg/ml) of purified Serratia
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Serum neutralization assays
At higher concentrations of antitoxin se-
rum, i.e., lower dilution, the morphological
changes induced by VT1, VT2 and CNF
toxins from E. coli on Vero cells were clearly
evident after 24 h. The results of neutraliza-
tion studies showed that antiserum against S.
marcescens cytotoxin did not neutralize the
biological activity of these toxins (Figure 5).
Genotypic analysis (PCR)
The assays showed that S. marcescens
isolates do not amplify any detectable frag-
ment, being characterized as negative for
amplification by PCR gene sequence for
VT1, VT2 and CNF toxins.
Discussion
The S. marcescens cytotoxin used in the
present study was purified to homogeneity
from a culture supernatant grown in Davis
minimal medium (8) by ion-exchange chro-
matography on a DEAE Sepharose Fast Flow
column and submitted to gel filtration on a
Figure 4. Morphological changes
induced by purified Serratia mar-
cescens cytotoxin (2 CD50 dose)
in CHO cells stained with toluidin
blue (100X). A, Typical morphol-
ogy of the control cells; B, cyto-
plasmic retraction, nuclear com-
pactation and cytoplasmic bleb-
bing (arrowheads) after 30 min
of treatment.
Table 1. Characteristics of toxins that were compared with Serratia marcescens cytotoxin in this study.
Bacterial toxin Type of effect Sensitive cell lines* Time of cytopathic Reference
effect**
S. marcescens Cell rounding, cytoplasmic CHO, HEp-2, HeLa 15 min Present
cytotoxin retraction study
S. marcescens Vacuolization, cell lysis Erythrocytes, 10 min 7
hemolysin HeLa, HEp-2
E. coli VT1 Round cells with a shriveled Vero, HeLa 24 h 19
appearance
E. coli VT2 Round cells with a shriveled Vero, HeLa 24 h 19
appearance
E. coli CNF Formation of giant cells, HeLa, Vero 24 h 19
multinucleation
*The most common cells used for the cytotoxicity assays.
**Approximate time for the appearance of a cytopathic effect after toxin addition.
Hemolysis assays
S. marcescens cytotoxin did not show
hemolytic activity in the liquid hemolytic
assay, even when treated with crude cyto-
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Sephadex G100 column. The fractions with
cytotoxic activity were eluted in the third
peak (Figure 1B, horizontal bar) and re-
vealed a single protein band by SDS electro-
phoresis (Figure 2). The molecular mass of
the purified cytotoxin was estimated to be 47
to 50 kDa by gel filtration chromatography.
This method is based on a calibration curve
using proteins of known molecular masses
as markers (10). The results show that the
molecular mass of cytotoxin is apparently
different from extracellular proteases pro-
duced by this bacterium, which have molec-
ular masses of 56, 60 and 73 kDa (18).
However, this cytotoxin has not yet been
characterized in terms of proteolytic activ-
ity.
Figure 5. Effects of VT1 and CNF
toxins on Vero cells in seroneu-
tralization assays. A, Vero con-
trol cells. B, Vero cells that re-
ceived mixtures of antiserum
against Serratia marcescens cy-
totoxin incubated for 1 h at 37ºC
with CNF toxin. C, Vero cells in-
oculated with mixtures of anti-
serum and VT toxin.
In order to choose a suitable target cell
line, we compared the sensitivity of several
cell lines to cytotoxin produced by clinical
isolates of S. marcescens. This represents an
important step related to the practical as-
pects of characterization of the cytotoxin.
CHO and HEp-2 cells appeared to be the
most sensitive to the toxic effects of S. mar-
cescens cytotoxin, followed by BHK-21,
HeLa, J774 and Vero cells (Figure 3), while
MA 104 cells were resistant to the toxin.
Thus, CHO cells were used as a model to
study the details of the mechanism of action
of the cytotoxin.
The pattern of morphological changes
gives a preliminary idea of the characteris-
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